Abingdon, United Kingdom
Adaptimmune is building a 67,000-sf biopharmaceutical R&D center in Abingdon in the United Kingdom. Designed by Nicholas Hare, the facility will provide laboratories, offices, and conference rooms for approximately 200 investigators and staff. Ground was broken on the project in October of 2015 and completion is expected in late 2016. The facility is located on the Milton Park technology campus and is being developed by MEPC.
Source
